(Updated - November 1, 2022 6:29 AM EDT)

Guggenheim analyst Yatin Suneja upgraded AnaptysBio (NASDAQ: ANAB) from Neutral to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE